A Multicenter Study Evaluating the Efficacy and Safety of BOTOX (Botulinum Toxin Type A) Purified Neurotoxin Complex as Headache Prophylaxis in Migraine Patients with 15 or More Headache Days per 4-Week Period in a 24-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase Followed by a 32-Week Open-Label Extension Phase.
Latest Information Update: 05 Aug 2019
Price :
$35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Sponsors Allergan
- 04 Aug 2019 Status changed from recruiting to completed.
- 25 May 2011 New trial record